Braun Bostich & Associates Inc. Invests $219,000 in Philip Morris International Inc. $PM

Braun Bostich & Associates Inc. acquired a new position in Philip Morris International Inc. (NYSE:PM) during the second quarter, HoldingsChannel reports. The institutional investor acquired 1,205 shares of the company’s stock, valued at approximately $219,000.

A number of other large investors have also recently made changes to their positions in PM. Kelly Lawrence W & Associates Inc. CA bought a new stake in shares of Philip Morris International during the first quarter valued at approximately $30,000. CBIZ Investment Advisory Services LLC boosted its position in shares of Philip Morris International by 405.0% during the first quarter. CBIZ Investment Advisory Services LLC now owns 202 shares of the company’s stock valued at $32,000 after purchasing an additional 162 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new stake in shares of Philip Morris International during the first quarter valued at approximately $34,000. Pacifica Partners Inc. boosted its position in shares of Philip Morris International by 115.0% during the first quarter. Pacifica Partners Inc. now owns 215 shares of the company’s stock valued at $35,000 after purchasing an additional 115 shares in the last quarter. Finally, Redmont Wealth Advisors LLC bought a new stake in shares of Philip Morris International during the first quarter valued at approximately $35,000. 78.63% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on PM. Jefferies Financial Group began coverage on Philip Morris International in a research report on Wednesday, July 9th. They set a “buy” rating and a $220.00 price target on the stock. JPMorgan Chase & Co. boosted their target price on Philip Morris International from $175.00 to $190.00 and gave the stock an “overweight” rating in a report on Thursday, July 10th. KGI Securities started coverage on Philip Morris International in a report on Monday, August 4th. They issued an “outperform” rating on the stock. Barclays dropped their target price on Philip Morris International from $225.00 to $220.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Finally, Bank of America boosted their target price on Philip Morris International from $182.00 to $200.00 and gave the stock a “buy” rating in a report on Wednesday, June 4th. Twelve equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, Philip Morris International presently has a consensus rating of “Moderate Buy” and a consensus price target of $184.91.

Philip Morris International Price Performance

Shares of NYSE:PM opened at $166.18 on Monday. The company has a market cap of $258.67 billion, a P/E ratio of 31.59, a PEG ratio of 2.41 and a beta of 0.49. Philip Morris International Inc. has a 1 year low of $116.12 and a 1 year high of $186.69. The stock’s fifty day moving average price is $168.89 and its 200-day moving average price is $167.83.

Philip Morris International (NYSE:PM) last announced its quarterly earnings results on Tuesday, July 22nd. The company reported $1.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.86 by $0.05. The firm had revenue of $10.14 billion for the quarter, compared to the consensus estimate of $10.33 billion. Philip Morris International had a negative return on equity of 120.86% and a net margin of 9.03%.The company’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.59 earnings per share. Philip Morris International has set its Q3 2025 guidance at 2.080-2.130 EPS. On average, sell-side analysts anticipate that Philip Morris International Inc. will post 7.14 earnings per share for the current year.

About Philip Morris International

Philip Morris International Inc operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches.